NovAccess Global Inc. (XSNX)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
Aug 19, 2026, 4:00 PM EST
NovAccess Global Market Cap
NovAccess Global has a market cap or net worth of $12.33 thousand as of August 20, 2026. Its market cap has decreased by -33.34% in one year.
Market Cap
12.33K
Enterprise Value
7.14M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
ChartMarket Cap Chart
Since September 18, 1998, NovAccess Global's market cap has decreased from 26.88M to 12.33K, a decrease of -99.95%. That is a compound annual growth rate of -24.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 12.33K | 100.00% |
| Dec 31, 2025 | 6.17K | -99.00% |
| Dec 31, 2024 | 616.52K | 28.36% |
| Dec 29, 2023 | 480.31K | -91.60% |
| Dec 30, 2022 | 5.72M | 10.69% |
| Dec 31, 2021 | 5.17M | 66.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Health Sciences Group | 20.51K |
| Scopus BioPharma | 16.83K |
| Regenicin | 15.35K |
| NanoLogix | 13.03K |
| Vaxxinity | 12.68K |
| ObsEva | 11.72K |
| Biostax | 10.77K |
| Syros Pharmaceuticals | 10.73K |